相关实验视频
Updated: May 23, 2025

07:50
Establishment of a Clinic-based Biorepository
Published on: May 29, 2017
6.4K
莫斯微图外科手术和改善皮肤癌的生存率:叙述性审查
Pablo Balado-Simó1, Miguel Mansilla-Polo2,3, Daniel Morgado-Carrasco4,5
1Servicio de Dermatología, Hospital Clínic de Barcelona, Universitat de Barcelona, Villarroel 170, 08036, Barcelona, Spain.
Dermatology and therapy
|April 20, 2025
概括
莫斯微图手术 (MMS) 可能改善特定皮肤癌的存活率,如头黑色素瘤和高风险状细胞癌. 然而,它的生存益处并非始终被证明是针对默克尔细胞癌或雷奥米奥萨尔科马的.
科学领域:
- 皮肤病学 皮肤病学
- 手术瘤学手术瘤学
- 在瘤学瘤学.
背景情况:
- 莫斯微图外科手术 (MMS) 已知皮肤癌复发率较低.
- 一些研究表明,MMS可能会改善患者的生存率.
- 在不同类型的皮肤癌中,MMS对存活率的影响需要全面评估.
研究的目的:
- 进行叙事审查,评估莫斯微图外科手术 (MMS) 对患者生存的影响.
- 评估使用MMS治疗的各种皮肤癌亚型的生存结果.
主要方法:
- 采用了一个叙事审查方法.
- 分析了回顾性研究,以收集有关MMS和患者存活率的数据.
主要成果:
- 在头部和部黑色素瘤,恶性lentigo,侵袭性皮肤状细胞癌 (cSCC),高风险皮肤纤维细胞突起瘤和一些恶性副瘤中,MMS可能会提高存活率.
- 与广泛切除相比,对默克尔细胞癌和乳腺神经瘤没有一致地证明MMS的生存率有所改善.
- 有限的证据表明,在用MMS治疗的乳外帕杰特病患者中,生存率有所改善.
结论:
- 对于特定的高风险皮肤癌,MMS显示出潜在的生存益处,需要对患者进行仔细的优先考虑和准入.
- 根据皮肤癌亚型,MMS的生存影响有很大差异.
- 需要进一步的研究来澄清MMS在某些罕见皮肤恶性瘤中的作用.
更多相关视频
相关概念视频
Skin Cancer
3.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.0K
Cancer Survival Analysis
318
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
318
Kaplan-Meier Approach
74
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
74

